News

A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists ...
A global review reveals over 100 new dementia drugs which could halt or even reverse the disease are going through clinical ...
Doctors are continuing to issue warnings regarding the illicit use of Ozempic, Wegovy and Mounjaro as weight loss injections, ...
Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in ...
Dementia experts have said that "hope is on the horizon" after a new review shows a rise in the number of potential drugs ...
The next big test is whether using Pluvicto can delay the advancement of prostate cancer enough to delay chemical castration, ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...
It would help the trials—and patients—if more people were tested for Alzheimer’s earlier on, so that they could be enrolled ...
How involved will GPs be in tirzepatide prescribing, and how do we approach conversations about 'prioritising' domestic ...
Mazdutide, used in the treatment of obesity and metabolic diseases, could become the first domestically-developed dual-target ...
Dementia experts have said that “hope is on the horizon” after a new review shows a rise in the number of potential drugs that could treat or prevent Alzheimer’s disease. Some 138 treatments are being ...
A new report from health data firm Truveta shows there was 50 per cent increase in American teenagers using the weight-loss drug Wegovy, particularly those living with obesity.